BioNote Statistics

Total Valuation

BioNote has a market cap or net worth of KRW 571.68 billion. The enterprise value is 225.20 billion.

Market Cap	571.68B
Enterprise Value	225.20B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

BioNote has 101.36 million shares outstanding. The number of shares has decreased by -0.78% in one year.

Current Share Class	101.36M
Shares Outstanding	101.36M
Shares Change (YoY)	-0.78%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	58.37%
Owned by Institutions (%)	0.20%
Float	14.27M

Valuation Ratios

The trailing PE ratio is 4.86.

PE Ratio	4.86
Forward PE	n/a
PS Ratio	4.97
PB Ratio	0.34
P/TBV Ratio	0.34
P/FCF Ratio	27.67
P/OCF Ratio	18.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.68, with an EV/FCF ratio of 10.90.

EV / Earnings	1.91
EV / Sales	1.96
EV / EBITDA	1.68
EV / EBIT	1.79
EV / FCF	10.90

Financial Position

The company has a current ratio of 35.92, with a Debt / Equity ratio of 0.00.

Current Ratio	35.92
Quick Ratio	33.06
Debt / Equity	0.00
Debt / EBITDA	0.13
Debt / FCF	0.17
Interest Coverage	61.31

Financial Efficiency

Return on equity (ROE) is 7.15% and return on invested capital (ROIC) is 0.70%.

Return on Equity (ROE)	7.15%
Return on Assets (ROA)	0.68%
Return on Invested Capital (ROIC)	0.70%
Return on Capital Employed (ROCE)	1.06%
Revenue Per Employee	386.22M
Profits Per Employee	394.80M
Employee Count	298
Asset Turnover	0.07
Inventory Turnover	1.95

Taxes

In the past 12 months, BioNote has paid 15.75 billion in taxes.

Income Tax	15.75B
Effective Tax Rate	11.81%

Stock Price Statistics

The stock price has increased by +21.86% in the last 52 weeks. The beta is 0.94, so BioNote's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+21.86%
50-Day Moving Average	5,651.40
200-Day Moving Average	5,210.45
Relative Strength Index (RSI)	52.48
Average Volume (20 Days)	45,133

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioNote had revenue of KRW 115.09 billion and earned 117.65 billion in profits. Earnings per share was 1,160.96.

Revenue	115.09B
Gross Profit	63.98B
Operating Income	18.39B
Pretax Income	133.40B
Net Income	117.65B
EBITDA	27.24B
EBIT	18.39B
Earnings Per Share (EPS)	1,160.96

Full Income Statement

Balance Sheet

The company has 349.96 billion in cash and 3.49 billion in debt, giving a net cash position of 346.48 billion or 3,418.23 per share.

Cash & Cash Equivalents	349.96B
Total Debt	3.49B
Net Cash	346.48B
Net Cash Per Share	3,418.23
Equity (Book Value)	1.70T
Book Value Per Share	16,891.14
Working Capital	407.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 31.61 billion and capital expenditures -10.94 billion, giving a free cash flow of 20.66 billion.

Operating Cash Flow	31.61B
Capital Expenditures	-10.94B
Free Cash Flow	20.66B
FCF Per Share	203.84

Full Cash Flow Statement

Margins

Gross margin is 55.59%, with operating and profit margins of 15.98% and 102.22%.

Gross Margin	55.59%
Operating Margin	15.98%
Pretax Margin	115.90%
Profit Margin	102.22%
EBITDA Margin	23.67%
EBIT Margin	15.98%
FCF Margin	17.95%

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 3.58%.

Dividend Per Share	200.00
Dividend Yield	3.58%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	17.23%
Buyback Yield	0.78%
Shareholder Yield	4.35%
Earnings Yield	20.58%
FCF Yield	3.61%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNote has an Altman Z-Score of 7.59 and a Piotroski F-Score of 6.

Altman Z-Score	7.59
Piotroski F-Score	6